Indeed refresher, and their appetite for small biotechs progressing clinical trials for anti acne products is growing fast, can't blame 'em with statistics showing that about 80% of people between the ages of 11 and 30 are affected by acne, and in some cases, acne persisting into middle age and beyond. According to World Health Organization, skin conditions can reduce quality of life, affecting physical, mental, and social capabilities. Research also implies that about 50% of women have faced adult acne and that the number of adult sufferers is on the rise.
Here's a breakdown of BioPharmX, they're doing A phase2 study (see my previous post circa projected sales for their BPX01):
Top Institutional Holders
Top Mutual Fund Holders
Holder Shares Date Reported % Out Value 1 Vivo Capital, LLC 12,814,286 Dec 31, 2016 18.92% 4,792,542 2 Franklin Resources, Inc 9,499,615 Dec 31, 2016 14.03% 3,552,856 3 EcoR1 Capital, LLC 1,342,000 Dec 31, 2016 1.98% 501,908 4 RTW Investments LP 1,273,128 Dec 31, 2016 1.88% 476,149 5 Sio Capital Management, LLC 1,143,400 Dec 31, 2016 1.69% 427,631 6 Sabby Management, LLC 708,046 Dec 31, 2016 1.05% 264,809 7 Vanguard Group, Inc. (The) 264,885 Dec 31, 2016 0.39% 99,066 8 PanAgora Asset Management, Inc. 80,735 Dec 31, 2016 0.12% 30,194 9 DAFNA Capital Management, LLC 77,031 Dec 31, 2016 0.11% 28,809 10 LPL Financial Corporation 40,000 Dec 31, 2016 0.06% 14,960
Holder Shares Date Reported % Out Value 1 Franklin Strategic Series-Franklin Biotechnology Discove 216,000 Jul 31, 2016 0.32% 155,520 2 Vanguard Total Stock Market Index Fund 144,070 Sep 30, 2016 0.21% 79,958 3 Claymore ETF Tr-Wilshire Micro Cap ETF 5,483 Nov 30, 2016 0.01% 1,699
- Forums
- ASX - By Stock
- BOT
- Ann: Export and Import Approvals for Clinical Studies Received
Ann: Export and Import Approvals for Clinical Studies Received, page-10
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
(20min delay)
|
|||||
Last
32.5¢ |
Change
-0.015(4.41%) |
Mkt cap ! $588.2M |
Open | High | Low | Value | Volume |
33.5¢ | 34.0¢ | 32.0¢ | $2.375M | 7.222M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 27500 | 32.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
33.0¢ | 262190 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 27500 | 0.325 |
29 | 976408 | 0.320 |
16 | 686802 | 0.315 |
12 | 880467 | 0.310 |
17 | 397501 | 0.305 |
Price($) | Vol. | No. |
---|---|---|
0.330 | 262190 | 5 |
0.335 | 561370 | 7 |
0.340 | 456207 | 8 |
0.345 | 153201 | 9 |
0.350 | 669957 | 14 |
Last trade - 16.10pm 10/07/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online